• Drug Watch
  • Digital Therapeutics
  • Diversity, Equity, Inclusion
  • Mental Health Awareness Month
  • Ethics
  • Cannabis
  • Climate Change
  • Psychedelics
  • Transcranial Magnetic Stimulation
  • COVID-19
  • Anxiety & Stress Disorders
  • Comorbidity
  • Cultural Psychiatry
  • Eating Disorders
  • Forensic Psychiatry
  • Geriatric Psychiatry
  • Integrative Psychiatry
  • Major Depressive Disorder
  • Mood Disorders
  • Addiction & Substance Use
  • Compulsive Disorders
  • Personality Disorders
  • Emergency Psychiatry
  • Psychopharmacology
  • Psychotherapy
  • PTSD
  • Psychosomatics
  • Neuropsychiatry
  • Schizophrenia/Psychosis
  • Suicide
  • Technology & Psychiatry
  • Tardive Dyskinesia
  • Bipolar Disorder
  • Special Populations
  • Sleep Disorders
  • Case Discussions
  • Child & Adolescent Psychiatry
  • ADHD
  • Major Depressive Disorder

Latest News

ADHD
Onyda XR: The First and Only Liquid Nonstimulant ADHD Medication

May 29th 2024

Onyda XR is the first and only liquid nonstimulant ADHD medication approved in the US and the only approved nonstimulant ADHD medication with nighttime dosing.

suicide
Two Tales of Death, Depression, and Suicide in Athletes

May 29th 2024

An analysis presented at the ASCP Annual Meeting explored the safety and tolerability of the treatment for alcohol and tobacco use disorders.
Efficacy of Semaglutide for the Treatment of Substance Use Disorders

May 29th 2024

polypharmacy
Polypharmacy in Older Adults

May 29th 2024

psychedelic
Psychedelics Safety Poll

May 29th 2024

Continuing Medical Education: Earn Credits With Psychiatric Times
Conference Coverage: Dive deep into intricate aspects of psychiatry with these articles.
Free E-Newsletter! Receive timely news, insights, and resources for clinicians on the go.
Psychiatric Times, Tales From the Clinic: The Art of Psychiatry, Series Editor: Nidal Moukaddam, MD, PhD
April's Theme: Substance Use Disorders
Print Publication: peer-reviewed and practice-oriented. A monthly journal by and for mental health clinicians.

Special Reports

polypharmacy
Polypharmacy in Older Adults

May 29th 2024

Clinicians should carefully weigh the risks and benefits of each prescribed medication for an older adult with neuropsychiatric diseases and periodically review all prescribed medications. Learn more here.

What are the risks and benefits of antipsychotic polypharmacy for the treatment of schizophrenia?
Correlates of Antipsychotic Polypharmacy in Taiwanese Patients With Schizophrenia

May 28th 2024

polypharmacy
Polypharmacy in Traumatic Brain Injury

May 23rd 2024

What are the connections between what we eat and disorders such as anxiety and depression?
Connections Between Food Additives and Psychiatric Disorders

April 25th 2024

Latest Videos
© 2024 MJH Life Sciences

All rights reserved.